GLASS LAB · Medical Aesthetics Evidence Index 303 cells · 19,226 papers · 5,969 top-tier evidence

Skin Quality · Facial dehydration / dry skin

PN PDRN injection evidence for Facial dehydration / dry skin

C 44.8 / 100 Insufficient 0 RCT/meta · 1 clinical/observational · 0 case · 3 total
Early-stage evidence

This is an early evidence stage based mainly on observational studies and case reports. Use it as supplementary reference, and follow your doctor's judgment for treatment decisions.

Grade combines the quantity and quality of the research, while direction is a separate signal showing how the papers assess effectiveness.

Median year 2026 Last 5 years 100% Positive results 67%

Known in Korea as

리쥬란리쥬란 S리쥬란 아이리쥬란 힐러

Procedure and brand names vary, but the evidence above applies to the same procedure mechanism.

Key papers

tier2 Midface volumization and skin quality enhancement with a hyaluronic acid-polynucleotide hybrid filler: a 24-week prospective open-label study. The Journal of dermatological treatment · 2026 · PMID 41626640

Abstract summary (English) BACKGROUND: Facial aging is characterized by midface volume loss from structural and dermal atrophy. OBJECTIVES: To evaluate the efficacy and safety of a hyaluronic acid-polynucleotide (HA-PN) hybrid filler for temporary restoration of anteromedial cheek volume. METHODS: In this single-center, open-label trial, 15 adults with moderate-to-severe anteromedial cheek volume loss (Mid-Face Volume Deficit Scale [MFVDS]...

Journal Article, Clinical Trial

View on PubMed
tier_other Hyaluronic Acid-like Skin Plumping and Radiance Benefits of a Porphyridium Sulfated Exopolysaccharide- and Natural PDRN-Rich Extract. Marine drugs · 2026 · PMID 41892958

Abstract summary (English) Red microalga Porphyridium cruentum produces a sulfated exopolysaccharide (EPS), which enables its survival in challenging intertidal and spray zones. Extracellular polysaccharide hyaluronic acid (HA) plays important roles in skin hydration, elasticity, and volume. However, with aging, HA decreases and loses effectiveness, reducing skin moisture retention and firmness, and increasing signs of aging.

Journal Article

View on PubMed
tier_other Efficacy of Polynucleotide-Based Therapy in Atopic Dermatitis Management. Journal of cosmetic dermatology · 2026 · PMID 41480692

Abstract summary (English) BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by persistent itching, dryness, redness, and recurrent eczematous lesions, significantly impacting patients' quality of life and psychological well-being. Despite various effective conventional treatments, innovative therapeutic approaches that simultaneously provide anti-inflammatory effects and enhanced skin hydration remain...

Journal Article

View on PubMed

Suggested interpretation

Limited evidence

Personalized evidence report

Tell us more about your concern
and the Glass Lab bot will build a personalized report for you.

Based on the PN PDRN injection · Facial dehydration / dry skin information on this page, we'll email you an evidence summary tailored to your skin condition and treatment stage.

Concerns of interest (select multiple)
Decision stage
← Other indications for the same procedure group  |  Other procedures for the same indication →